EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Qing Ye
Andreina Schoeberlein
Marko Turina
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ye, Q.
Right arrow Articles by Turina, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ye, Q.
Right arrow Articles by Turina, M.

Eur J Cardiothorac Surg 2000;17:449-454
© 2000 Elsevier Science NL

Tissue engineering in cardiovascular surgery: new approach to develop completely human autologous tissue

Qing Yea, Gregor Zündb, Stefan Jockenhoevela, Simon P. Hoerstrupb, Andreina Schoeberleinb, Jurg Grunenfelderb, Marko Turinab

a Department of Surgical Research, University Hospital, Rämistrasse 1000, CH-8091, Zurich, Switzerland
b Clinic for Cardiovascular Surgery, University Hospital, Rämistrasse 100, CH-8091 Zurich, Switzerland

Corresponding author. Tel.: +41-1-255-3801; fax: +41-1-255-4369
e-mail: gregor.zund{at}chi.usz.ch

Objective: In cardiovascular tissue engineering, three-dimensional scaffolds serve as physical supports and templates for cell attachment and tissue development. Currently used scaffolds are still far from ideal, they are potentially immunogenic and they show toxic degradation and inflammatory reactions. The aim of this study is to develop a new method for a three-dimensional completely autologous human tissue without using any scaffold materials. Methods: Human aortic tissue is harvested from the ascending aorta in the operation room and worked up to pure human myofibroblasts cultures. These human aortic myofibroblasts cultures (1.5x106 cells, passage 3) were seeded into 15-cm culture dishes. Cells were cultured with Dulbecco’ s modified Eagle's medium supplemented with 1 mM L-ascorbic acid 2-phosphate for 4 weeks to form myofibroblast sheets. The harvested cell sheets were folded to form four-layer sheets. The folded sheets were then framed up and cultured for another 4 weeks. Tissue development was evaluated by biochemical assay and light and electron microscopy. Results: After 4 weeks of culture in ascorbic acid supplemented medium, myofibroblasts formed thin cell sheets in culture dishes. The cell sheets presented in a multi-layered pattern surrounded by extracellular matrices. Cultured for additional 4 weeks on the frames, the folded sheets further developed into more solid and flexible tissues. Light microscopy documented a structure resembling to a native tissue with confluent extracellular matrix. Under transmission electron microscope, viable cells and confluent bundles of striated mature collagen fibers were observed. Hydroxyproline assays showed significant increase of collagen content after culturing on the frames and were 80.5% of that of natural human pericardium. Conclusions: Improved cell culture technique may render human aortic myofibroblasts to a native tissue-like structure. A three-dimensional completely autologous human tissue may be further developed on the base of this structure with no show toxic degradation or inflammatory reactions.

Key Words: Tissue engineering • Autologous human tissue • Cardiovascular • Scaffolds




This article has been cited by other articles:


Home page
FASEB J.Home page
B. Zavan, V. Vindigni, S. Lepidi, I. Iacopetti, G. Avruscio, G. Abatangelo, and R. Cortivo
Neoarteries grown in vivo using a tissue-engineered hyaluronan-based scaffold
FASEB J, August 1, 2008; 22(8): 2853 - 2861.
[Abstract] [Full Text] [PDF]


Home page
Phil Trans R Soc BHome page
P. M Taylor
Biological matrices and bionanotechnology
Phil Trans R Soc B, August 29, 2007; 362(1484): 1313 - 1320.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
P. M Dohmen, S. Ozaki, E. Verbeken, J. Yperman, W. Flameng, and W. F Konertz
Tissue Engineering of an Auto-Xenograft Pulmonary Heart Valve
Asian Cardiovasc Thorac Ann, March 1, 2002; 10(1): 25 - 30.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2000 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.